777 replies to this topic

[ImmInst]

BioTime Inc. (BTX) Jumps 8.05% on September 04
Equities.com - 1 hour ago

BioTime Inc. ($BTX) was among the biggest gainers on the Russell 2000 for Friday September 04 as the stock popped 8.05% to $3.22, representing a gain of $0.24 per share.

View the full article

[ImmInst]

Healthcare Gainers: BioTime, Inc. (NYSEMKT:BTX), Ariad Pharmaceuticals Inc ...
Stock Transcript - 1 hour ago

BioTime, Inc. (NYSE MKT: BTX), announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of BioTime's common shares beginning on Tuesday, September 8, 2015 under the ticker symbol BTX.

View the full article

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Rally 4.55%
Insider Trading Report - 2 hours ago

Shares of BioTime, Inc. (NYSEMKT:BTX) rose by 4.55% in the past week and 11.81% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 8.23% and the outperformance increases to 20.9% for the last 4 weeks.

Biotech Stocks Update: Dyax Corp. (NASDAQ:DYAX), Sequenom Inc. (NASDAQ:SQNM ... - Seneca Globe

View the full article

[ImmInst]

Why Need to Watch: CTI BioPharma Corp. (NASDAQ:CTIC), BioTime, Inc. (NYSEMKT ...
Stock Transcript - 30 minutes ago

On 4 September, BioTime, Inc. (NYSEMKT:BTX) announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of BioTime's common shares beginning on Tuesday, September 8, 2015 under the ticker symbol BTX.

View the full article

[ImmInst]

Stocks in Focus: Citigroup Inc. (NYSE:C), BioTime, Inc. (NYSEMKT:BTX ...
Stock Transcript - 1 hour ago

John Gerspach, Chief Financial Officer of Citigroup Inc. (NYSE:C), will present at the Barclays Global Financial Services Conference on Wednesday, September 16, 2015.

View the full article

[ImmInst]

Trending Tickers: TearLab Corporation (NASDAQ:TEAR), BioTime, Inc. (NYSEMKT ...
Stock Transcript - 1 hour ago

On 31st August, BioTime, Inc. (NYSE MKT: BTX) announced that subsidiary Asterias Biotherapeutics, Inc., a biotechnology company focused on the emerging field of regenerative medicine, reported that the third patient was successfully dosed at ...

View the full article

[ImmInst]

Mid Week Pre-Market Ratings: ChinaNet Online Holdings, Inc. (CNET), BioTime ...
WallStreet Scope - 2 hours ago

ChinaNet Online Holdings, Inc. (CNET) performed up on Tuesday with a 7 day performance of -0.28% ending the day at $0.86, gaining 3.33%.

View the full article

[ImmInst]

BioTime's subsidiary Asterias Biotherapeutics Inc settles patent interference proceedings
Reuters Key Development - May 28, 2014

View the full article

[ImmInst]

Biotime Inc's OncoCyte announces initial data from ongoing clinical study of Collagen Type X
Reuters Key Development - Apr 20, 2015

View the full article

[ImmInst]

BioTime Inc and its subsidiary OncoCyte Corp announced positive clinical results of PanC-Dx
Reuters Key Development - Apr 20, 2015

View the full article

[ImmInst]

BioTime Inc Subsidiary ES Cell International and GE Healthcare Cross-License patents in the Field of Cell Assays for Drug Testing
Reuters Key Development - Dec 15, 2014

View the full article

[ImmInst]

Biotime Inc's subsidiary Cell Cure Neurosciences receives FDA authorization to initiate phase I/IIa trial of Embryonic Stem Cell-Derived OpRegen
Reuters Key Development - Nov 3, 2014

View the full article

[ImmInst]

BioTime Inc closes $31 million financing
Reuters Key Development - Oct 9, 2014

View the full article

[ImmInst]

Biotime Inc's subsidiary Cell Cure Neurosciences Ltd. files an IND with FDA for OpRegen Designed to Treat Patients with Dry-AMD
Reuters Key Development - Oct 6, 2014

View the full article

[ImmInst]

BioTime Inc and subsidiaries to raise $31 mln through sales of common shares
Reuters Key Development - Oct 6, 2014

View the full article

[ImmInst]

Biotime subsidiary OncoCyte Corp expands clinical development of Bladder Cancer Diagnostic by initiating multi-site clinical trial
Reuters Key Development - Jul 31, 2014

View the full article

[ImmInst]

BioTime Inc 's Asterias Biotherapeutics raises $13 mln in equity financing
Reuters Key Development - Jun 17, 2014

View the full article

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Rally 2.17%
Insider Trading Report - 8 hours ago

Shares of BioTime, Inc. (NYSEMKT:BTX) rose by 2.17% in the past week and 22.76% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 0.1% and the outperformance increases to 30.93% for the last 4 weeks.

View the full article

[ImmInst]

BioTime, Inc. Agrees to Sell $8.58 Million of Common Shares
MarketWatch - 2 hours ago

BioTime, Inc., a pioneer in regenerative medicine, is a clinical-stage biotechnology company. BioTime and its subsidiaries are leveraging their industry-leading experience in pluripotent stem cell technology and a broad intellectual property portfolio ...

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Rally 2.17% - Insider Trading Report
Form 8-K BIOTIME INC For: Sep 14 - StreetInsider.com

View the full article

[ImmInst]

Worth Watching Stocks: BioTime, Inc. (NYSEMKT:BTX), Willbros Group Inc. (NYSE ...
Stock Transcript - 2 hours ago

BioTime, Inc. (NYSE MKT and TASE: BTX) announced that it has agreed to sell 2,607,401 of its common shares, no par value, at an offering price of $3.29 per share, for a gross purchase price of approximately $8.58 million, to selected investors ...

View the full article

[ImmInst]

Morning Watch List: USG Corporation (NYSE:USG), BioTime, Inc. (NYSEMKT:BTX ...
Benchmark Monitor - 2 hours ago

USG Corp (NYSE:USG), on Tuesday said it has agreed to sell its interest in the Knauf-USG Joint Venture to Knauf Aquapanel GmbH for about €48 million cash.

View the full article

[ImmInst]

Broadwood Partners Lp Bought Biotime Inc's Shares
OctaFinance.com - 2 hours ago

Broadwood Partners Lp has filled a SC 13D/A form regarding Biotime Inc . Filing Link: 000091957415006936. Per Broadwood Partners Lp's filing, the filler reported increased stake in the company by 11.87% to 20,477,304 shares.

View the full article

[ImmInst]

Top Stories: BioTime, Inc. (NYSEMKT:BTX), Denbury Resources Inc. (NYSE:DNR ...
Benchmark Monitor - 26 minutes ago

BioTime, Inc. (NYSE MKT and TASE: BTX) on Sep 14, announced the appointment of Cavan Redmond as an independent member of the Board of Directors of BioTime's subsidiary OncoCyte Corporation.

View the full article

[ImmInst]

Biotime Inc Broadwood Partners Lp increased Stake
FinancialBio.com - 2 hours ago

Broadwood Partners Lp has filed a SC 13D/A form about Biotime Inc. Filing Text: 000091957415006936. From Broadwood Partners Lp's filing, we see increased stake in the stock by 11.87% to 20,477,304 shares.

View the full article

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Rally 8.81%
American Trade Journal - 22 hours ago

Shares of BioTime, Inc. (NYSEMKT:BTX) rose by 8.81% in the past week and 39.3% for the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 6.28%.

Why Need to Watch: BioTime, Inc. (NYSEMKT:BTX), Kirkland's Inc. (NASDAQ:KIRK ... - Stock Transcript

View the full article

[ImmInst]

BioTime, Inc. Short Interest Update
American Trade Journal - 2 hours ago

The short interest in BioTime, Inc. (NYSEMKT:BTX) has increased from 6,034,874 on August 31,2015 to 6,354,402 on September 15,2015.

View the full article

[ImmInst]

BioTime, Inc. Short Interest Update
American Trade Journal - 13 hours ago

The short interest in BioTime, Inc. (NYSEMKT:BTX) has increased from 6,034,874 on August 31,2015 to 6,354,402 on September 15,2015.

View the full article

[ImmInst]

BioTime, Inc. Agrees to Sell Up to $20.7 Million of Common Shares
Business Wire (press release) - 1 hour ago

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE: BTX) today announced that it has agreed to sell up to $20.7 million of its common shares in a registered direct offering to select investment funds in Israel that hold shares of ...

View the full article

[ImmInst]

BioTime, Inc. Short Interest Update
American Trade Journal - 16 hours ago

The short interest in BioTime, Inc. (NYSEMKT:BTX) has increased from 6,034,874 on August 31,2015 to 6,354,402 on September 15,2015.

View the full article

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Drops by -2.23%
OTC Outlook - 1 hour ago

BioTime, Inc. (NYSEMKT:BTX) has dropped 2.23% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 13.64% in the last 4 weeks.

View the full article